CBS deleted its “ready to worship” tweet in response to the Satan-themed Grammy Awards performance.
“This is going to be special,” Sam Smith, the non-binary “Unholy” singer, tweeted ahead of his demonic set with transgender singer Kim Petras that was sponsored by Pfizer.
“…you can say that again,” CBS tweeted in response. “We are ready to worship!”
The bizarre tweet from the Paramount Global television broadcasting company immediately drew backlash.
“Did CBS just admit it worships Satan?” the Media Research Center tweeted Monday.
CBS deleted its tweet later in the day Monday.
. @CBS has deleted their tweet after saying they’re “ready to worship” ahead Sam Smith’s Satanic Grammys performance pic.twitter.com/2vxZCmt1C5
— Jillian Anderson (@Jillie_Alexis) February 7, 2023
“.@CBS has deleted their tweet after saying they’re “ready to worship” ahead Sam Smith’s Satanic Grammys performance,” Jillian Anderson tweeted.
CBS celebrated the historic win by Smith and Petras:
Kim Petras and Sam Smith have become the first transgender and nonbinary winners of the Grammy Award for Best Pop Duo/Group Performance, respectively. The duo took home the award for their hit single, “Unholy,” which they also performed during the awards ceremony.
CBS also tweeted “nothing tops moments like these!” with a photo of Petras in the demonic cage.
National radio host Todd Starnes said the disturbing performance “was further evidence of how Hollywood has surrendered to evil,” adding, “they openly worship the prince of darkness.”
It also received rebuke from Sen. Ted Cruz (R-TX) and Rep. Marjorie Taylor Greene (R-GA):
The Grammy’s featured Sam Smith’s demonic performance and was sponsored by Pfizer.
— Marjorie Taylor Greene 🇺🇸 (@mtgreenee) February 6, 2023
And the Satanic Church now has an abortion clinic in NM that requires its patients to perform a satanic ritual before services.
American Christians need to get to work.
pic.twitter.com/0dZ5g6ZM5S
Pfizer responded in a statement to Newsweek.
“We sponsored the overall Grammy’s event, not any particular performance. Beyond that, we don’t comment on our efforts to raise awareness,” a Pfizer spokesperson said.
Caleb Parke is the SMG managing editor. Follow him on Twitter, Facebook, Instagram, and connect with him at calebparke.com.